Literature DB >> 32118391

[Cause analysis and treatment strategies of "recurrence" with novel coronavirus pneumonia (COVID-19) patients after discharge from hospital].

L Zhou1, K Liu1, H G Liu1.   

Abstract

With a large number of COVID-19 patients discharging from hospital, some had showed re-fever and positive nucleic acid test after discharge from hospital. This might be due to the biological characteristics of 2019-nCoV, and might also be related to the basic disease, clinical status, glucocorticoid using, sample sampling, processing and detecting of patients, and some even related to the re-infection or secondary bacterial virus infection. Therefore, we suggest that in view of this phenomenon, further stratified management of discharge from hospital should be carried out on the basis of guidelines, especially for patients with advanced age, underlying diseases or severe or critical pneumonia. For those patients who can't completely deoxygenate for a long time after hospitalization, individualized treatment methods and different discharge evaluation criteria should be adopted to ensure the complete cure of patients and prevent recurrencing after discharge from hospital.

Entities:  

Keywords:  COVID-19; Cause analysis; Discharge from hospital; Recurrence; Treatment strategies

Mesh:

Year:  2020        PMID: 32118391     DOI: 10.3760/cma.j.cn112147-20200229-00219

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  46 in total

1.  Recurrent viral RNA positivity and candidiasis findings in hospitalized patients with COVID-19.

Authors:  Malihe Naderi; Seyed Amir Soltani; Akram Taheri Rad; Zahra Mehrbakhsh; Sina Sodagar; Alireza Tahamtan; Seyedeh Sedigheh Hosseini
Journal:  Future Microbiol       Date:  2022-04-25       Impact factor: 3.553

2.  Clinical Characteristics of Patients With Re-admitted of Novel Coronavirus 2019 (nCOVID-19) in Wenzhou, China.

Authors:  Xinchun Ye; Yuping Yuan; Risheng Huang; Aiqiong Cheng; Zhijie Yu; Ziyang Huang; Rongrong Chen; Xiangao Jiang; Yuanliang Zheng; Jichan Shi
Journal:  Front Public Health       Date:  2021-05-12

Review 3.  COVID-19: Is reinfection possible?

Authors:  Aratã Oliveira Cortez Costa; Humberto de Carvalho Aragão Neto; Ana Paula Lopes Nunes; Ricardo Dias de Castro; Reinaldo Nóbrega de Almeida
Journal:  EXCLI J       Date:  2021-03-02       Impact factor: 4.068

Review 4.  COVID-19: Molecular and Cellular Response.

Authors:  Shamila D Alipoor; Esmaeil Mortaz; Hamidreza Jamaati; Payam Tabarsi; Hasan Bayram; Mohammad Varahram; Ian M Adcock
Journal:  Front Cell Infect Microbiol       Date:  2021-02-11       Impact factor: 5.293

5.  Medium Term Follow-Up of 337 Patients With Coronavirus Disease 2019 (COVID-19) in a Fangcang Shelter Hospital in Wuhan, China.

Authors:  Nao Yan; Wei Wang; Yongzhe Gao; Junhui Zhou; Jiuhong Ye; Zhipeng Xu; Jing Cao; Junjian Zhang
Journal:  Front Med (Lausanne)       Date:  2020-07-03

6.  Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?

Authors:  Marie Gousseff; Pauline Penot; Laure Gallay; Dominique Batisse; Nicolas Benech; Kevin Bouiller; Rocco Collarino; Anne Conrad; Dorsaf Slama; Cédric Joseph; Adrien Lemaignen; François-Xavier Lescure; Bruno Levy; Matthieu Mahevas; Bruno Pozzetto; Nicolas Vignier; Benjamin Wyplosz; Dominique Salmon; Francois Goehringer; Elisabeth Botelho-Nevers
Journal:  J Infect       Date:  2020-06-30       Impact factor: 6.072

Review 7.  Patient follow-up after discharge after COVID-19 pneumonia: Considerations for infectious control.

Authors:  Zhong Zheng; Zhixian Yao; Ke Wu; Junhua Zheng
Journal:  J Med Virol       Date:  2020-08-21       Impact factor: 20.693

8.  COVID-19 infection recurrence presenting with meningoencephalitis.

Authors:  M Mardani; S Alireza Nadji; K Aghazadeh Sarhangipor; A Sharifi-Razavi; M Baziboroun
Journal:  New Microbes New Infect       Date:  2020-07-23

9.  Re-evaluation of retested nucleic acid-positive cases in recovered COVID-19 patients: Report from a designated transfer hospital in Chongqing, China.

Authors:  Yan Chen; Weizhi Bai; Bin Liu; Jian Huang; Irakoze Laurent; Feng Chen; Wuquan Deng; Xiaoqiu Xiao
Journal:  J Infect Public Health       Date:  2020-06-07       Impact factor: 3.718

10.  Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies.

Authors:  Xuemin Guo; Lizhu Zeng; Zhen Huang; Yongjun He; Zhuojin Zhang; Zhixiong Zhong
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.